Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Thoracic Surgery

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 301 articles:
HTML format
Text format



Single Articles


    June 2019
  1. CHANDIRAMANI R, Chen H, Aoi S, Giustino G, et al
    Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.
    Catheter Cardiovasc Interv. 2019 Jun 14. doi: 10.1002/ccd.28369.
    PubMed     Text format     Abstract available


  2. CHEN W, Lu D, Huang Z, Xiao L, et al
    Is a prolongation of bivalirudin infusion needed in patients with STEMI undergoing percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2019 Jun 10. doi: 10.1002/ccd.28368.
    PubMed     Text format    


  3. KEYMEL S, Papadopoulos G, Minol JP, Blehm A, et al
    Patients with severe aortic stenosis and coexisting pulmonary hypertension treated by transapical transcatheter aortic valve replacement-Is there a need for increased attention?
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28358.
    PubMed     Text format     Abstract available


  4. TRIPATHI B, Yeh RW, Bavishi CP, Sardar P, et al
    Etiologies, trends, and predictors of readmission in ST-elevation myocardial infarction patients undergoing multivessel percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28344.
    PubMed     Text format     Abstract available


  5. STACHON P, Kaier K, Heidt T, Bothe W, et al
    Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008-2015.
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28361.
    PubMed     Text format     Abstract available


  6. PRICE DJ, Levy MS
    CYP2C19 pharmacogenetics in patients undergoing coronary stent placement: Is it time to test everyone?
    Catheter Cardiovasc Interv. 2019;93:1253-1254.
    PubMed     Text format     Abstract available


  7. BLOCK PC, Lisko JC
    Thrombocytopenia after transcatheter aortic valve replacement: What is really going on?
    Catheter Cardiovasc Interv. 2019;93:1352-1353.
    PubMed     Text format     Abstract available


    May 2019
  8. MONTERO CABEZAS JM, Abou R, Goedemans L, Aguero J, et al
    Procedural-related coronary atrial branch occlusion during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction and atrial arrhythmias at follow-up.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28351.
    PubMed     Text format     Abstract available


  9. AMAT-SANTOS IJ, Gutierrez H, Sathananthan J, Webb JG, et al
    Fracture of small Mitroflow(R) aortic bioprosthesis following valve-in-valve transcatheter aortic valve replacement with ACURATE neo valve-From bench testing to clinical practice.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28347.
    PubMed     Text format     Abstract available


  10. KIM N, Lee JH, Jang SY, Bae MH, et al
    Intravascular modality-guided versus angiography-guided percutaneous coronary intervention in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 May 27. doi: 10.1002/ccd.28359.
    PubMed     Text format     Abstract available


  11. CHEN Y, Yin T, Xi S, Zhang S, et al
    A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28325.
    PubMed     Text format     Abstract available


  12. KOYAMA Y, Yamamoto M, Kagase A, Tsujimoto S, et al
    Prognostic impact and periprocedural complications of chronic steroid therapy in patients following transcatheter aortic valve replacement: Propensity-matched analysis from the Japanese OCEAN registry.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28332.
    PubMed     Text format     Abstract available


  13. BARBARAWI M, Kheiri B, Zayed Y, Barbarawi O, et al
    Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28280.
    PubMed     Text format     Abstract available


  14. DESCH S, Thiele H
    Letter commenting on: Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis (Kundu et al. Catheter Cardio
    Catheter Cardiovasc Interv. 2019 May 15. doi: 10.1002/ccd.28331.
    PubMed     Text format    


  15. KUNDU A, Sardar P, Kakouros N, Fisher DZ, et al
    Rebuttal: Response to letter by Desch et al. regarding "Outcomes of multivessel vs. culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-ana
    Catheter Cardiovasc Interv. 2019 May 15. doi: 10.1002/ccd.28334.
    PubMed     Text format    


  16. IBRAHIM H, Vapheas E, Shah B, AlKhalil A, et al
    Preprocedural P2Y12 inhibition and decrease in platelet count following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 May 6. doi: 10.1002/ccd.28320.
    PubMed     Text format     Abstract available


  17. SEKIGUCHI M, Muramatsu T, Kishi K, Muto M, et al
    Assessment of reattempted percutaneous coronary intervention strategy for chronic total occlusion after prior failed procedures: Analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2019 May 6. doi: 10.1002/ccd.28315.
    PubMed     Text format     Abstract available


  18. KARATASAKIS A, Brilakis ES
    Chronic total occlusion percutaneous coronary intervention failure: Learning from failure.
    Catheter Cardiovasc Interv. 2019;93:1039-1040.
    PubMed     Text format     Abstract available


  19. KALYANASUNDARAM A, Seth A
    Chronic total occlusion or non-chronic total occlusion percutaneous coronary intervention: Do myocytes really care?
    Catheter Cardiovasc Interv. 2019;93:1067-1068.
    PubMed     Text format     Abstract available


  20. ASHLEY KE, Hillegass WB
    Costs of postoperative delirium with transcatheter aortic valve replacement: Improved yet still present.
    Catheter Cardiovasc Interv. 2019;93:1137.
    PubMed     Text format     Abstract available


    April 2019
  21. JUNQUERA L, Freitas-Ferraz AB, Padron R, Silva I, et al
    Intraprocedural high-degree atrioventricular block or complete heart block in transcatheter aortic valve replacement recipients with no prior intraventricular conduction disturbances.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28323.
    PubMed     Text format     Abstract available


  22. SEPPELT PC, Zappel J, Weiler H, Mas-Peiro S, et al
    Aortic valve replacement in patients with preexisting liver disease: Transfemoral approach with favorable survival.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28319.
    PubMed     Text format     Abstract available


  23. MOHANANEY D, Villablanca P, Gupta T, Ranka S, et al
    Association of peripheral artery disease with in-hospital outcomes after endovascular transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28310.
    PubMed     Text format     Abstract available


  24. DE MIGUEL-DIEZ J, Lopez-de-Andres A, Hernandez-Barrera V, Mendez-Bailon M, et al
    Impact of COPD on outcomes in hospitalized patients treated with transcatheter aortic valve implantation or surgical aortic valve replacement in Spain.
    Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28321.
    PubMed     Text format     Abstract available


  25. VAN NUNEN LX, van 't Veer M, Zimmermann FM, Wijnbergen I, et al
    Intra-aortic balloon pump counterpulsation in extensive myocardial infarction with persistent ischemia: The SEMPER FI pilot study.
    Catheter Cardiovasc Interv. 2019 Apr 24. doi: 10.1002/ccd.28289.
    PubMed     Text format     Abstract available


  26. RAJ L, Mehra A, Shavelle DM
    Mixed aortic valve disease treated with transcatheter aortic valve replacement in a high risk patient presenting with acute decompensated heart failure.
    Catheter Cardiovasc Interv. 2019 Apr 10. doi: 10.1002/ccd.28221.
    PubMed     Text format     Abstract available


  27. KWOK CS, Sirker A, Farmer AD, Kontopantelis E, et al
    In-hospital gastrointestinal bleeding following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Apr 8. doi: 10.1002/ccd.28222.
    PubMed     Text format     Abstract available


    March 2019
  28. AKTUERK D, Jansz P, Shaw M, Muller DWM, et al
    Successful repositioning of apically tethered transcatheter mitral valve replacement in the off-bypass, beating heart.
    Catheter Cardiovasc Interv. 2019 Mar 27. doi: 10.1002/ccd.28210.
    PubMed     Text format     Abstract available


  29. SAIA F, Palmerini T, Compagnone M, Battistini P, et al
    Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Mar 27. doi: 10.1002/ccd.28211.
    PubMed     Text format     Abstract available


  30. ABAWI M, van Gils L, Agostoni P, van Mieghem NM, et al
    Impact of baseline cigarette smoking status on clinical outcome after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Mar 22. doi: 10.1002/ccd.28175.
    PubMed     Text format     Abstract available


  31. BELARDI JA, Lamelas PM
    Transcatheter aortic valve replacement hemodynamic durability: Still in question?
    Catheter Cardiovasc Interv. 2019;93:739.
    PubMed     Text format     Abstract available


  32. KUMAR V, Seth A
    Transcatheter aortic valve replacement: Protect the kidneys to protect the patient.
    Catheter Cardiovasc Interv. 2019;93:749-750.
    PubMed     Text format     Abstract available


    February 2019
  33. UESHIMA D, Masiero G, Schiavo A, Badawy MRA, et al
    Time course of the survival advantage of transcatheter over surgical aortic valve replacement: Interplay between sex and patient risk profile.
    Catheter Cardiovasc Interv. 2019 Feb 28. doi: 10.1002/ccd.28124.
    PubMed     Text format     Abstract available


  34. ATTI V, Patel NJ, Kumar V, Tripathi B, et al
    Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Feb 27. doi: 10.1002/ccd.28161.
    PubMed     Text format     Abstract available


  35. AL-OGAILI A, Fugar S, Okoh A, Kolkailah AA, et al
    Trends in complete heart block after transcatheter aortic valve replacement: A population based analysis.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28156.
    PubMed     Text format     Abstract available


  36. RAMZY J, Andrianopoulos N, Roberts L, Duffy SJ, et al
    Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28145.
    PubMed     Text format     Abstract available


  37. CHEN B, Dean LS
    HAS-BLED for predicting transfemoral transcatheter aortic valve replacement outcomes: Enough to tamponade the problem?
    Catheter Cardiovasc Interv. 2019;93:E202-E203.
    PubMed     Text format     Abstract available


  38. WANG Y, Zhao HW, Wang CF, Fan CY, et al
    Efficacy and safety of bivalirudin during percutaneous coronary intervention in high-bleeding-risk elderly patients with chronic total occlusion: A prospective randomized controlled trial.
    Catheter Cardiovasc Interv. 2019 Feb 5. doi: 10.1002/ccd.28087.
    PubMed     Text format     Abstract available


  39. HARFOUCH B, Prasad A
    The use of ultra low contrast volume during percutaneous coronary intervention and risk of acute kidney injury: How low can we go?
    Catheter Cardiovasc Interv. 2019;93:231-232.
    PubMed     Text format     Abstract available


  40. HALL AB, Brilakis ES
    Hybrid 2.0: Subintimal plaque modification for facilitation of future success in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019;93:199-201.
    PubMed     Text format     Abstract available


    January 2019
  41. RUBIMBURA V, Rostain L, Duval AM, Akakpo S, et al
    Outcomes and safety of same-day discharge after percutaneous coronary intervention: A 10-year single-center study.
    Catheter Cardiovasc Interv. 2019 Jan 31. doi: 10.1002/ccd.28084.
    PubMed     Text format     Abstract available


  42. WU K, Huang Z, Zhong Z, Liao H, et al
    Predictors, treatment, and long-term outcomes of coronary perforation during retrograde percutaneous coronary intervention via epicardial collaterals for recanalization of chronic coronary total occlusion.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28093.
    PubMed     Text format     Abstract available


  43. REED GW, Rossi JE, Masri A, Griffin BP, et al
    Angiographic predictors of adverse outcomes after percutaneous coronary intervention in patients with radiation associated coronary artery disease.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28107.
    PubMed     Text format     Abstract available


  44. AL-HIJJI MA, Zack CJ, Nkomo VT, Pislaru SV, et al
    Left ventricular remodeling and function after transapical versus transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Jan 27. doi: 10.1002/ccd.28074.
    PubMed     Text format     Abstract available


  45. SHARMA SK, Bolduan RW, Patel MR, Martinsen BJ, et al
    Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28099.
    PubMed     Text format     Abstract available


  46. RATTANAWONG P, Kanitsoraphan C, Kewcharoen J, Riangwiwat T, et al
    Chronic kidney disease is associated with increased mortality and procedural complications in transcatheter aortic valve replacement: a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28102.
    PubMed     Text format     Abstract available


  47. FAGGIONI M, Baber U, Chandrasekhar J, Sartori S, et al
    Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2019 Jan 17. doi: 10.1002/ccd.28033.
    PubMed     Text format     Abstract available


  48. JIA S, Zhao Y, Yang J, Zhao X, et al
    Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.
    Catheter Cardiovasc Interv. 2019 Jan 13. doi: 10.1002/ccd.28060.
    PubMed     Text format     Abstract available


  49. KHEIRI B, Abdalla A, Osman M, Barbarawi M, et al
    Personalized antiplatelet therapy in patients with coronary artery disease undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2019 Jan 10. doi: 10.1002/ccd.28075.
    PubMed     Text format     Abstract available


  50. POTTS J, Nagaraja V, Al Suwaidi J, Brugaletta S, et al
    The influence of Elixhauser comorbidity index on percutaneous coronary intervention outcomes.
    Catheter Cardiovasc Interv. 2019 Jan 10. doi: 10.1002/ccd.28072.
    PubMed     Text format     Abstract available


  51. WANG H, Ning X, Zhu C, Yin D, et al
    Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jan 7. doi: 10.1002/ccd.28057.
    PubMed     Text format     Abstract available


  52. OKOH AK, Haik N, Singh S, Kaur K, et al
    Discharge disposition of older patients undergoing trans-catheter aortic valve replacement and its impact on survival.
    Catheter Cardiovasc Interv. 2019 Jan 7. doi: 10.1002/ccd.28069.
    PubMed     Text format     Abstract available


  53. CHAN CY, Wu EB, Yan BP, Tsuchikane E, et al
    Procedure failure of chronic total occlusion percutaneous coronary intervention in an algorithm driven contemporary Asia-Pacific Chronic Total Occlusion Club (APCTO Club) multicenter registry.
    Catheter Cardiovasc Interv. 2019 Jan 3. doi: 10.1002/ccd.28064.
    PubMed     Text format     Abstract available


  54. AHN SG, Lee JW, Youn YJ, Lee SH, et al
    In-hospital outcome differences between transradial and transfemoral coronary approaches: Data from the Korean percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2019 Jan 2. doi: 10.1002/ccd.28032.
    PubMed     Text format     Abstract available


    December 2018
  55. CANNON LA, Kimmelstiel CD, White A, Hill R, et al
    Clinical outcomes following implantation of the ION paclitaxel-eluting platinum chromium coronary stent in routine clinical practice: Results of the ION U.S. post-approval study.
    Catheter Cardiovasc Interv. 2018 Dec 30. doi: 10.1002/ccd.28044.
    PubMed     Text format     Abstract available


  56. KUNDU A, Sardar P, Kakouros N, Malhotra R, et al
    Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Dec 28. doi: 10.1002/ccd.28062.
    PubMed     Text format     Abstract available


  57. CHOI CH, Cheng V, Malaver D, Kon N, et al
    A comparison of valve-in-valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves.
    Catheter Cardiovasc Interv. 2018 Dec 27. doi: 10.1002/ccd.28039.
    PubMed     Text format     Abstract available


  58. LIU S, Song C, Zhao Y, Guan C, et al
    Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28030.
    PubMed     Text format     Abstract available


  59. NEUPANE S, Khawaja O, Edla S, Singh H, et al
    Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28045.
    PubMed     Text format     Abstract available


  60. FABRIS E, Ottervanger JP, Hermanides RS, Ten Berg JM, et al
    Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28043.
    PubMed     Text format     Abstract available


  61. ELGENDY IY, Mahmoud AN, Elbadwai A, Elgendy AY, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians.
    Catheter Cardiovasc Interv. 2018 Dec 19. doi: 10.1002/ccd.28050.
    PubMed     Text format     Abstract available


  62. POTTER BJ, Thompson C, Green P, Clancy S, et al
    Incremental cost and length of stay associated with postprocedure delirium in transcatheter and surgical aortic valve replacement patients in the United States.
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28014.
    PubMed     Text format     Abstract available


  63. GAO G, Zhao Y, Zhang D, He Y, et al
    Is the SYNTAX Score II applicable in all percutaneous coronary intervention patients?
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28053.
    PubMed     Text format     Abstract available


  64. IANNACCONE M, D'ascenzo F, Piazza F, De Benedictis M, et al
    Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: A meta-analysis of randomized controlled trials and propensity score adjusted studies.
    Catheter Cardiovasc Interv. 2018 Dec 13. doi: 10.1002/ccd.28037.
    PubMed     Text format     Abstract available


  65. CORCOS T
    Distal radial access for coronary angiography and percutaneous coronary intervention: A state-of-the-art review.
    Catheter Cardiovasc Interv. 2018 Dec 11. doi: 10.1002/ccd.28016.
    PubMed     Text format     Abstract available


  66. ANDO T, Aoi S, Ashraf S, Villablanca PA, et al
    Transradial versus transfemoral percutaneous coronary intervention of left main disease: A systematic review and meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28025.
    PubMed     Text format     Abstract available


  67. FERNANDEZ-LOPEZ L, Chevalier B, Lefevre T, Spaziano M, et al
    Implementation of the transradial approach as an alternative vascular access for transcatheter aortic valve replacement guidance: Experience from a high-volume center.
    Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28024.
    PubMed     Text format     Abstract available


  68. GUEDENEY P, Tchetche D, Petronio AS, Mehilli J, et al
    Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
    Catheter Cardiovasc Interv. 2018 Dec 4. doi: 10.1002/ccd.28012.
    PubMed     Text format     Abstract available


    November 2018
  69. YOUNIS A, Orvin K, Nof E, Barabash IM, et al
    The effect of periprocedural beta blocker withdrawal on arrhythmic risk following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Nov 29. doi: 10.1002/ccd.28017.
    PubMed     Text format     Abstract available


  70. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute
    Catheter Cardiovasc Interv. 2018 Nov 25. doi: 10.1002/ccd.27985.
    PubMed     Text format     Abstract available


  71. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    An overview of percutaneous coronary intervention in dialysis patients: Insights from a Japanese nationwide registry.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27986.
    PubMed     Text format     Abstract available


  72. ABDELGHANI M, Allali A, Kaur J, Hemetsberger R, et al
    Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis-patient mismatch after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27977.
    PubMed     Text format     Abstract available


  73. WALTERS D, Reeves RR, Patel M, Naghi J, et al
    Complex robotic compared to manual coronary interventions: 6- and 12-month outcomes.
    Catheter Cardiovasc Interv. 2018 Nov 19. doi: 10.1002/ccd.27867.
    PubMed     Text format     Abstract available


  74. SCHUMACHER SP, Driessen RS, Stuijfzand WJ, Raijmakers PG, et al
    Recovery of myocardial perfusion after percutaneous coronary intervention of chronic total occlusions is comparable to hemodynamically significant non-occlusive lesions.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27945.
    PubMed     Text format     Abstract available


  75. XU JJ, Song Y, Jiang P, Gao Z, et al
    Effect of prior stroke on long-term outcomes of percutaneous coronary interventions in Chinese patients: A large single-center study.
    Catheter Cardiovasc Interv. 2018 Nov 13. doi: 10.1002/ccd.27705.
    PubMed     Text format     Abstract available


  76. HABIB N, Mahmoodi BK, Suttorp MJ, Kelder JC, et al
    Long-term results of carotid stenting and risk factors in patients with severe carotid artery stenosis undergoing subsequent cardiac surgery.
    Catheter Cardiovasc Interv. 2018 Nov 9. doi: 10.1002/ccd.27947.
    PubMed     Text format     Abstract available


  77. SPINA R, Khalique O, Kodali S, Bapat VN, et al
    Urgent transcatheter aortic valve replacement for severe acute aortic regurgitation following open mitral valve surgery.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27954.
    PubMed     Text format     Abstract available


  78. ANDO T, Adegbala O, Villablanca PA, Briasoulis A, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement in non-teaching hospitals.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27968.
    PubMed     Text format     Abstract available


  79. KUMAR A, Block PC
    Paravalvular leak after transcatheter aortic valve replacement: Avoid it or treat it if you can!
    Catheter Cardiovasc Interv. 2018;92:981-982.
    PubMed     Text format     Abstract available


    October 2018
  80. USKELA S, Karkkainen JM, Eranen J, Siljander A, et al
    Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
    Catheter Cardiovasc Interv. 2018 Oct 31. doi: 10.1002/ccd.27950.
    PubMed     Text format     Abstract available


  81. ADJEDJ J, Picard F, Mogi S, Iwasaki K, et al
    In vitro flow and optical coherence tomography comparison of two bailout techniques after failed provisional stenting for bifurcation percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2018 Oct 23. doi: 10.1002/ccd.27718.
    PubMed     Text format     Abstract available


  82. THONGHONG T, Bieliauskas G, De Backer O, Sondergaard L, et al
    Economical cost of percutaneous vascular closure with ProGlide and Prostar XL following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 22. doi: 10.1002/ccd.27697.
    PubMed     Text format    


  83. AZZALINI L, Uretsky B, Brilakis ES, Colombo A, et al
    Contrast modulation in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Oct 22. doi: 10.1002/ccd.27869.
    PubMed     Text format     Abstract available


  84. PINEDA AM, Kevin Harrison J, Kleiman NS, Reardon MJ, et al
    Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 20. doi: 10.1002/ccd.27928.
    PubMed     Text format     Abstract available


  85. LI J, Patel SM, Nadeem F, Thakker P, et al
    Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 12. doi: 10.1002/ccd.27894.
    PubMed     Text format     Abstract available


  86. MISUMIDA N, Pagath M, Ogunbayo GO, Wilson RE, et al
    Characteristics of and current practice patterns of pacing for high-degree atrioventricular block after transcatheter aortic valve implantation in comparison to surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 9. doi: 10.1002/ccd.27915.
    PubMed     Text format     Abstract available


  87. NELSON BC, Chadderdon S, Song H, Zahr FE, et al
    Bioprosthetic aortic valve leaflet disruption with high energy electrocautery to prevent coronary artery obstruction during valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27721.
    PubMed     Text format     Abstract available


  88. WELT FGP, Klein LW, Tamis-Holland J, Blankenship J, et al
    Views of Appropriate Use Criteria for catheterization and percutaneous coronary revascularization by practicing interventional cardiologists: Results of a survey of American College of Cardiology Interventional Section members.
    Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27931.
    PubMed     Text format     Abstract available


  89. FELDMANN K, Cami E, Safian RD
    Planning percutaneous coronary interventions using computed tomography angiography and fractional flow reserve-derived from computed tomography: A state-of-the-art review.
    Catheter Cardiovasc Interv. 2018 Oct 4. doi: 10.1002/ccd.27817.
    PubMed     Text format     Abstract available


  90. CASE BC, Geiser KM, Torguson R, Pichard AD, et al
    Comparison of coronary revascularization appropriateness for non-acute coronary syndrome cases under the 2017 update vs the 2012 appropriate use criteria.
    Catheter Cardiovasc Interv. 2018 Oct 2. doi: 10.1002/ccd.27895.
    PubMed     Text format     Abstract available


  91. BUCHANAN KD, Rogers T, Steinvil A, Koifman E, et al
    Role of contractile reserve as a predictor of mortality in low-flow, low-gradient severe aortic stenosis following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 2. doi: 10.1002/ccd.27914.
    PubMed     Text format     Abstract available


    September 2018
  92. RAWASIA WF, Khan MS, Usman MS, Siddiqi TJ, et al
    Safety and efficacy of transcatheter aortic valve replacement for native aortic valve regurgitation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27840.
    PubMed     Text format     Abstract available


  93. BONIN M, Guerin P, Olive JM, Jordana F, et al
    Standardized bench test evaluation of coronary stents: Biomechanical characteristics.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27912.
    PubMed     Text format     Abstract available


  94. MORI M, Bin Mahmood SU, Geirsson A, Yun JJ, et al
    Trends in volume and risk profiles of patients undergoing isolated surgical and transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27855.
    PubMed     Text format     Abstract available


  95. SAITO Y, Kitahara H, Okuya Y, Nakayama T, et al
    Novel predictor of target vessel revascularization after coronary stent implantation: Intraluminal intensity of blood speckle on intravascular ultrasound.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27859.
    PubMed     Text format     Abstract available


  96. ALQAHTANI F, Ziada K, Rihal CS, Alkhouli M, et al
    Incidence and outcomes of early percutaneous coronary intervention after isolated valve surgery.
    Catheter Cardiovasc Interv. 2018 Sep 30:e27874. doi: 10.1002/ccd.27874.
    PubMed     Text format     Abstract available


  97. EDRIS A, Bartel T, Tuzcu EM, Suri RM, et al
    Alcohol septal ablation for outflow tract obstruction after transcatheter aortic and mitral valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27723.
    PubMed     Text format     Abstract available


  98. KESSLER M, Seeger J, Wohrle J, Rottbauer W, et al
    Intra-aortic balloon counterpulsation pump in heart failure patients during MitraClip implantation-A propensity-score matched analysis.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27717.
    PubMed     Text format     Abstract available


  99. SHAH R, Jovin IS, Chaudhry A, Haji SA, et al
    Safety and efficacy of switching from unfractionated heparin to bivalirudin during primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27828.
    PubMed     Text format     Abstract available


  100. MADUKAUWA-DAVID ID, Midha PA, Sharma R, McLain K, et al
    Characterization of aortic root geometry in transcatheter aortic valve replacement patients.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27805.
    PubMed     Text format     Abstract available


  101. BAVARIA JE, Tommaso CL, Brindis RG, Carroll JD, et al
    MULTISOCIETY EXPERT CONSENSUS SYSTEMS OF CARE DOCUMENT 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27811.
    PubMed     Text format    


  102. FUKUTOMI M, Toriumi S, Ogoyama Y, Oba Y, et al
    Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
    Catheter Cardiovasc Interv. 2018 Sep 23:e27896. doi: 10.1002/ccd.27896.
    PubMed     Text format     Abstract available


  103. GARCIA S, Mbai M, Kelly R, Bertog S, et al
    Simultaneous transfemoral transcatheter aortic valve replacement and trans-septal mitral valve-in-ring implantation after partial laceration of an Alfieri stitch.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27875.
    PubMed     Text format     Abstract available


  104. KIMURA T, Nishibori Y, Miki K, Maruyama T, et al
    Open sesame technique in percutaneous coronary intervention for ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27787.
    PubMed     Text format     Abstract available


  105. DADU RT, Xu J, Rehman H, von Ballmoos MW, et al
    Optimal positioning of self-expanding valves before deployment decreases paravalvular regurgitation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27829.
    PubMed     Text format     Abstract available


  106. SHAUKAT A, Mooney M, Burke MN, Brilakis ES, et al
    Use of chronic total occlusion percutaneous coronary intervention techniques for treating acute vessel closure.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27868.
    PubMed     Text format     Abstract available


  107. OKUMURA H, Hayashi H, Harada M, Mikuri M, et al
    Retrograde percutaneous coronary intervention for acute myocardial infarction following blunt chest trauma.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27836.
    PubMed     Text format     Abstract available


  108. BOI A, Sanna F, Rossi A, Loi B, et al
    Acute myocardial infarction secondary to blunt chest trauma in motorcycle accident: A rare combination where percutaneous coronary intervention and intravascular imaging optimization are needed.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27725.
    PubMed     Text format     Abstract available


  109. BUTERA G, Mansour NB, De Marco F
    Emergency trans-catheter coronary intervention for left main compression secondary to pulmonary hypertension in a 4-year-old child.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27796.
    PubMed     Text format     Abstract available


  110. RAFIQ A, Chutani S, Krim NR
    Coronary intervention and arteria lusoria-Not simple as it may seem.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27803.
    PubMed     Text format     Abstract available


    August 2018
  111. GURM HS, Seth M, Dixon SR, Michael Grossman P, et al
    Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2018 Aug 25. doi: 10.1002/ccd.27819.
    PubMed     Text format     Abstract available


  112. KHAN JM, Lederman RJ
    Adventures across the second dimension: Predicting left ventricular outflow tract obstruction following transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2018;92:388-389.
    PubMed     Text format    


  113. CHATTERJEE A, Hillegass WB
    Surgical aortic valve replacement and transcatheter aortic valve implantation for severe aortic stenosis: Equipoise remains a tenable assumption.
    Catheter Cardiovasc Interv. 2018;92:431-432.
    PubMed     Text format    


    July 2018
  114. TAM DY, Vo TX, Wijeysundera HC, Dvir D, et al
    Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Jul 19. doi: 10.1002/ccd.27686.
    PubMed     Text format     Abstract available


  115. CHEN GC, Lu XM, Song YM, Gyawail L, et al
    A 3-year experience of a simple, novel technique for accurate ostial/non-ostial coronary stenting: The buddy balloon anchor stent technique.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27667.
    PubMed     Text format     Abstract available


  116. ROGERS T, Gai J, Torguson R, Okubagzi PG, et al
    Predicted magnitude of alternate access in the contemporary transcatheter aortic valve replacement era.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27668.
    PubMed     Text format     Abstract available


  117. SMILOWITZ NR, Mohananey D, Razzouk L, Weisz G, et al
    Impact and trends of intravascular imaging in diagnostic coronary angiography and percutaneous coronary intervention in inpatients in the United States.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27673.
    PubMed     Text format     Abstract available


  118. NOAMAN S, Goh CY, Vogrin S, Brennan AL, et al
    Comparison of short-term clinical outcomes of proximal versus nonproximal lesion location in patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction: The PROXIMITI study.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27665.
    PubMed     Text format     Abstract available


  119. WUSTROW I, Sarafoff N, Haller B, Rossner L, et al
    Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27678.
    PubMed     Text format     Abstract available


  120. RILEY RF, McCabe JM, Kalra S, Lazkani M, et al
    Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27679.
    PubMed     Text format     Abstract available


  121. DAMLUJI AA, Murman M, Byun S, Moscucci M, et al
    Alternative access for transcatheter aortic valve replacement in older adults: A collaborative study from France and United States.
    Catheter Cardiovasc Interv. 2018 Jul 3. doi: 10.1002/ccd.27690.
    PubMed     Text format     Abstract available


  122. SHLOFMITZ E, Jeremias A
    Precision percutaneous coronary intervention: Is optical coherence tomography co-registration the future?
    Catheter Cardiovasc Interv. 2018;92:38-39.
    PubMed     Text format     Abstract available


    June 2018
  123. BLOCK PC
    Transcatheter treatment of aortic regurgitation: Still enigmatic.
    Catheter Cardiovasc Interv. 2018;91:1352-1353.
    PubMed     Text format     Abstract available


    May 2018
  124. AKODAD M, Huet F, Dupuy AM, Lotierzo M, et al
    Letter to the editor concerning "comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary interventi
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27618.
    PubMed     Text format    


  125. JACKSON M, Austin D, Kwok CS, Rashid M, et al
    The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society.
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27642.
    PubMed     Text format     Abstract available


  126. TAMEZ H, Genereux P, Yeh RW, Amin AP, et al
    Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study.
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27638.
    PubMed     Text format     Abstract available


    April 2018
  127. SETO AH, Shroff A, Abu-Fadel M, Blankenship JC, et al
    Length of stay following percutaneous coronary intervention: An expert consensus document update from the society for cardiovascular angiography and interventions.
    Catheter Cardiovasc Interv. 2018 Apr 24. doi: 10.1002/ccd.27637.
    PubMed     Text format     Abstract available


  128. VILLABLANCA PA, Mohananey D, Ramakrishna H
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Apr 16. doi: 10.1002/ccd.27639.
    PubMed     Text format    


  129. DE BACKER O, Sondergaard L
    TAVR in bicuspid aortic valve stenosis: "We are not there yet" to draw final conclusions.
    Catheter Cardiovasc Interv. 2018;91:984-985.
    PubMed     Text format     Abstract available


  130. KRISHNAN SK, Dean LS
    Looking for the bare necessities.
    Catheter Cardiovasc Interv. 2018;91:956-957.
    PubMed     Text format     Abstract available


  131. BURZOTTA F, Trani C
    TAVR technique tries to go higher than bicuspid valve hurdles.
    Catheter Cardiovasc Interv. 2018;91:995-996.
    PubMed     Text format     Abstract available


  132. TURI ZG
    The under-appreciated and still under-investigated consequences of "supersized" access and closure.
    Catheter Cardiovasc Interv. 2018;91:945-946.
    PubMed     Text format     Abstract available


    March 2018
  133. NDREPEPA G, Kastrati A
    Rebuttal: Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27617.
    PubMed     Text format    


  134. KINDYA B, Ouzan E, Lerakis S, Gonen E, et al
    Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27607.
    PubMed     Text format     Abstract available


  135. HONDA Y, Yamawaki M, Araki M, Tada N, et al
    Impact of HAS-BLED score to predict trans femoral transcatheter aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27596.
    PubMed     Text format     Abstract available


  136. DE PALMA R, Settergren M, Ruck A, Linder R, et al
    Impact of percutaneous femoral arteriotomy closure using the MANTA(TM) device on vascular and bleeding complications after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27595.
    PubMed     Text format     Abstract available


  137. MOHDNAZRI SR, Karamasis GV, Al-Janabi F, Cook CM, et al
    The impact of coronary chronic total occlusion percutaneous coronary intervention upon donor vessel fractional flow reserve and instantaneous wave-free ratio: Implications for physiology-guided PCI in patients with CTO.
    Catheter Cardiovasc Interv. 2018 Mar 22. doi: 10.1002/ccd.27587.
    PubMed     Text format     Abstract available


  138. EITAN A, Witt J, Stripling J, Haselbach T, et al
    Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli >/=26 mm.
    Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27588.
    PubMed     Text format     Abstract available


  139. NIIDA T, Murai T, Yonetsu T, Kanaji Y, et al
    Coronary physiological assessment combining fractional flow reserve and index of microcirculatory resistance in patients undergoing elective percutaneous coronary intervention with grey zone fractional flow reserve.
    Catheter Cardiovasc Interv. 2018 Mar 8. doi: 10.1002/ccd.27570.
    PubMed     Text format     Abstract available


  140. ANANTHAKRISHNA R, Kristanto W, Liu L, Chan SP, et al
    Incidence and predictors of target lesion failure in a multiethnic Asian population receiving the SYNERGY coronary stent: A prospective all-comers registry.
    Catheter Cardiovasc Interv. 2018 Mar 7. doi: 10.1002/ccd.27577.
    PubMed     Text format     Abstract available


  141. XIE R, Hillegass WB
    Long-term survival prospects of patients undergoing percutaneous coronary intervention: Envisioning the future.
    Catheter Cardiovasc Interv. 2018;91:696.
    PubMed     Text format     Abstract available


  142. TAJTI P, Karmpaliotis D, Alaswad K, Toma C, et al
    Prevalence, Presentation and Treatment of 'Balloon Undilatable' Chronic Total Occlusions: Insights from a Multicenter US Registry.
    Catheter Cardiovasc Interv. 2018;91:657-666.
    PubMed     Text format     Abstract available


  143. TAKAGI H, Ando T, Umemoto T
    Drug-eluting stents versus coronary artery bypass grafting for left-main coronary artery disease.
    Catheter Cardiovasc Interv. 2018;91:697-709.
    PubMed     Text format     Abstract available


  144. MIZOTE I, Schirmer J, Schafer U
    A case of successful Mitraclip implantation in a patient having a large coaptation gap under extracorporeal membrane oxygenation (ECMO).
    Catheter Cardiovasc Interv. 2018;91:827-830.
    PubMed     Text format     Abstract available


    February 2018
  145. DAUTOV R, Ybarra LF, Nguyen CM, Gibrat C, et al
    Incidence, predictors and longer-term impact of troponin elevation following hybrid chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Feb 26. doi: 10.1002/ccd.27545.
    PubMed     Text format     Abstract available


  146. AZARRAFIY R, Albuquerque FN, Carrillo RG, Cohen MG, et al
    Coil embolization to successfully treat annular rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27546.
    PubMed     Text format     Abstract available


  147. HIOKI H, Watanabe Y, Kozuma K, Yamamoto M, et al
    Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27547.
    PubMed     Text format     Abstract available


  148. MURAI T, Yonetsu T, Kanaji Y, Usui E, et al
    Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
    Catheter Cardiovasc Interv. 2018 Feb 15. doi: 10.1002/ccd.27529.
    PubMed     Text format     Abstract available


  149. BENSON L
    PPVI in children under 20 kilograms: A quid pro quo?
    Catheter Cardiovasc Interv. 2018;91:495-496.
    PubMed     Text format     Abstract available


  150. MARTIN MH, Shahanavaz S, Peng LF, Asnes JD, et al
    Percutaneous transcatheter pulmonary valve replacement in children weighing less than 20 kg.
    Catheter Cardiovasc Interv. 2018;91:485-494.
    PubMed     Text format     Abstract available


  151. GASPARINI GL, Oreglia JA, Reimers B
    Self-apposing stent-assisted coil embolization for the treatment of coronary artery aneurysm.
    Catheter Cardiovasc Interv. 2018;91:470-474.
    PubMed     Text format     Abstract available


  152. WALDO SW, O'Donnell CI, Prouse A, Plomondon ME, et al
    Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program.
    Catheter Cardiovasc Interv. 2018;91:425-433.
    PubMed     Text format     Abstract available


  153. ADJEDJ J, Toth GG, Pellicano M, Wijns W, et al
    Reversed single string technique for coronary bifurcation stenting-First report of case demonstrations in vitro.
    Catheter Cardiovasc Interv. 2018;91:396-401.
    PubMed     Text format     Abstract available


  154. VAN BOMMEL RJ, Lemmert ME, van Mieghem NM, van Geuns RJ, et al
    Occurrence and predictors of acute stent recoil-A comparison between the xience prime cobalt chromium stent and the promus premier platinum chromium stent.
    Catheter Cardiovasc Interv. 2018;91:E21-E28.
    PubMed     Text format     Abstract available


  155. CAMPOS CM, Caixeta A, Franken M, Bartorelli AL, et al
    Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND an
    Catheter Cardiovasc Interv. 2018;91:387-395.
    PubMed     Text format     Abstract available


  156. GASIOR P, Cheng Y, Estrada EA, Jenn McGregor, et al
    Novel ultrahigh molecular weight amorphous PLLA bioresorbable coronary scaffold upsized up to 0.8 mm beyond nominal diameter: An OCT and histopathology study in porcine coronary artery model.
    Catheter Cardiovasc Interv. 2018;91:378-386.
    PubMed     Text format     Abstract available


  157. BAILEY SR
    Catheterization and Cardiovascular Interventions CIT Special Issue: Editor In Chief Editorial.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format    


  158. MEHRAN R
    The History of Clinical Research Workshop at CIT: A Ten Year Perspective.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format    


  159. ZIVELONGHI C, van Kuijk JP, Nijenhuis V, Poletti E, et al
    First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm.
    Catheter Cardiovasc Interv. 2018 Feb 7. doi: 10.1002/ccd.27539.
    PubMed     Text format     Abstract available


  160. MCNEICE AH, Brooks M, Hanratty CG, Stevenson M, et al
    A retrospective study of radiation dose measurements comparing different cath lab X-ray systems in a sample population of patients undergoing percutaneous coronary intervention for chronic total occlusions.
    Catheter Cardiovasc Interv. 2018 Feb 7. doi: 10.1002/ccd.27541.
    PubMed     Text format     Abstract available


  161. SAWANT AC, Bhardwaj A, Banerjee K, Jobanputra Y, et al
    Fractional flow reserve guided percutaneous coronary intervention results in reduced ischemic myocardium and improved outcomes.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27525.
    PubMed     Text format     Abstract available


  162. FACCINI A, Butera G
    Tricuspid regurgitation as a complication of Edwards Sapien XT valve implantation in pulmonary position a problem to deal with.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27527.
    PubMed     Text format     Abstract available


  163. LIU X, He Y, Zhu Q, Gao F, et al
    Supra-annular structure assessment for self-expanding transcatheter heart valve size selection in patients with bicuspid aortic valve.
    Catheter Cardiovasc Interv. 2018 Feb 5. doi: 10.1002/ccd.27467.
    PubMed     Text format     Abstract available


  164. TAKAGI H, Mitta S, Ando T
    Long-term survival after transcatheter versus surgical aortic valve replacement for aortic stenosis: A meta-analysis of observational comparative studies with a propensity-score analysis.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27521.
    PubMed     Text format     Abstract available


  165. WITBERG G, Lador A, Yahav D, Kornowski R, et al
    Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27518.
    PubMed     Text format     Abstract available


  166. HEUSER RR
    Perforations and how to manage: The coronary interventionalist and peripheral interventionalist working together for a solution.
    Catheter Cardiovasc Interv. 2018;91:308-309.
    PubMed     Text format     Abstract available


  167. PLITT A, Dangas G
    Cardiac enzyme elevation after coronary revascularization.
    Catheter Cardiovasc Interv. 2018;91:224-225.
    PubMed     Text format     Abstract available


  168. MISUMIDA N, Moliterno DJ
    Hybrid coronary revascularization: Time for a new comparator?
    Catheter Cardiovasc Interv. 2018;91:213-214.
    PubMed     Text format     Abstract available


  169. TAN C, Dean LS
    Conscious sedation for TAVR: A wave of the future?
    Catheter Cardiovasc Interv. 2018;91:343-344.
    PubMed     Text format     Abstract available


  170. DI MARIO C, Sorini Dini C
    Maximal efficiency is required to minimize complications and hospital stay after TAVR.
    Catheter Cardiovasc Interv. 2018;91:354-355.
    PubMed     Text format     Abstract available


  171. SCHNEIDER HE, Gravenhorst V, Paul T, Jacobshagen C, et al
    Insufficiency of a Damus-Kaye-Stansel anastomosis in a Fontan patient: Transfemoral implantation of an Edwards Sapien 3 valve.
    Catheter Cardiovasc Interv. 2018;91:292-295.
    PubMed     Text format     Abstract available


  172. LLURI G, Levi DS, Miller E, Hageman A, et al
    Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2018;91:277-284.
    PubMed     Text format     Abstract available


  173. MCGARVEY M, Ali O, Iqbal MB, Ilsley C, et al
    A feasibility and safety study of intracoronary hemodilution during primary coronary angioplasty in order to reduce reperfusion injury in myocardial infarction.
    Catheter Cardiovasc Interv. 2018;91:234-241.
    PubMed     Text format     Abstract available


  174. SARDAR P, Kundu A, Bischoff M, Chatterjee S, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis.
    Catheter Cardiovasc Interv. 2018;91:203-212.
    PubMed     Text format     Abstract available


    January 2018
  175. LIU S, Song C, Zhao Y, Zhu C, et al
    The impact of acquired thrombocytopenia on long-term outcomes of patients undergoing elective percutaneous coronary intervention: An analysis of 8,271 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Jan 25. doi: 10.1002/ccd.27498.
    PubMed     Text format     Abstract available


  176. BADRI M, Shapiro T, Wang Y, Minges KE, et al
    Adoption of the transradial approach for percutaneous coronary intervention and rates of vascular complications following transfemoral procedures: Insights from NCDR.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27490.
    PubMed     Text format     Abstract available


  177. EL SABBAGH A, Eleid MF, Matsumoto JM, Anavekar NS, et al
    Three-dimensional prototyping for procedural simulation of transcatheter mitral valve replacement in patients with mitral annular calcification.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27488.
    PubMed     Text format     Abstract available


  178. DONG H, Che W, Jiang X, Peng M, et al
    Carotid artery stenting followed by open heart surgery in 323 patients: One-year results and influencing factors.
    Catheter Cardiovasc Interv. 2018 Jan 22. doi: 10.1002/ccd.27486.
    PubMed     Text format     Abstract available


  179. KAGASE A, Yamamoto M, Shimura T, Kodama A, et al
    Impact of pre-procedural hyponatremia on clinical outcomes after transcatheter aortic valve replacement: A propensity-matched analysis.
    Catheter Cardiovasc Interv. 2018 Jan 11. doi: 10.1002/ccd.27483.
    PubMed     Text format     Abstract available


  180. GARCIA S, Kelly R, Mbai M, Gurevich S, et al
    Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
    Catheter Cardiovasc Interv. 2018 Jan 9. doi: 10.1002/ccd.27478.
    PubMed     Text format     Abstract available


  181. ALASTI M, Rashid H, Rangasamy K, Kotschet E, et al
    Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
    Catheter Cardiovasc Interv. 2018 Jan 4. doi: 10.1002/ccd.27463.
    PubMed     Text format     Abstract available


  182. MALIK SA, Brilakis ES, Pompili V, Chatzizisis YS, et al
    Lost and found: Coronary stent retrieval and review of literature.
    Catheter Cardiovasc Interv. 2018 Jan 4. doi: 10.1002/ccd.27464.
    PubMed     Text format     Abstract available


  183. IVERSON A, Stanberry L, Garberich R, Antos A, et al
    Impact of sleep deprivation on the outcomes of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Jan 3. doi: 10.1002/ccd.27471.
    PubMed     Text format    


  184. ROGERS T, Lederman RJ
    Percutaneous transaxillary access for TAVR: Another opportunity to stay out of the chest.
    Catheter Cardiovasc Interv. 2018;91:157-158.
    PubMed     Text format     Abstract available


  185. AUBERSON D, Gray W
    Good enough...isn't.
    Catheter Cardiovasc Interv. 2018;91:148-149.
    PubMed     Text format     Abstract available


  186. VO MN, Brilakis ES, Grantham JA
    Novel use of cutting balloon to treat subintimal hematomas during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2018;91:53-56.
    PubMed     Text format     Abstract available


  187. SHAHANAVAZ S, Rockefeller T, Nicolas R, Balzer D, et al
    Fracturing a dysfunctional Edwards Perimount bioprosthetic valve to facilitate percutaneous valve-in-valve placement of SAPIEN 3 valve with modified delivery system.
    Catheter Cardiovasc Interv. 2018;91:81-85.
    PubMed     Text format     Abstract available


  188. BOUDJEMLINE Y
    A new one-step procedure for pulmonary valve implantation of the melody valve: Simultaneous prestenting and valve implantation.
    Catheter Cardiovasc Interv. 2018;91:64-70.
    PubMed     Text format     Abstract available


  189. GASPARINI GL, Oreglia JA, Garbo R
    The trap and occlude technique for retrograde wire externalization during chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2018;91:57-63.
    PubMed     Text format     Abstract available


  190. CAPRETTI G, Carlino M, Colombo A, Azzalini L, et al
    Rotational atherectomy in the subadventitial space to allow safe and successful chronic total occlusion recanalization: Pushing the limit further.
    Catheter Cardiovasc Interv. 2018;91:47-52.
    PubMed     Text format     Abstract available


  191. GOLESKI PJ, Reisman M, Don CW
    Reversible thrombotic aortic valve restenosis after valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018;91:165-168.
    PubMed     Text format     Abstract available


  192. NERLA R, Cremonesi A, Castriota F
    Successful percutaneous paravalvular leak closure followed by transfemoral aortic lotus valve-in-valve implantation in a degenerated surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2018;91:169-174.
    PubMed     Text format     Abstract available


    December 2017
  193. GOLDSWEIG AM, Kennedy KF, Kolte D, Abbott JD, et al
    Predictors of patient radiation exposure during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Dec 27. doi: 10.1002/ccd.27452.
    PubMed     Text format     Abstract available


  194. KIM JH, Kim BK, Kim S, Ahn CM, et al
    Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27420.
    PubMed     Text format     Abstract available


  195. WANG DD, Eng MH, Greenbaum AB, Myers E, et al
    Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR).
    Catheter Cardiovasc Interv. 2017 Dec 11. doi: 10.1002/ccd.27447.
    PubMed     Text format     Abstract available


  196. MILLAN-ITURBE O, Sawaya FJ, Lonborg J, Chow DHF, et al
    Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
    Catheter Cardiovasc Interv. 2017 Dec 7. doi: 10.1002/ccd.27440.
    PubMed     Text format     Abstract available


  197. RASHID HN, McCormick LM, Talman AH, Ihdayhid AR, et al
    Effect of aorto-ventricular angulation on procedural success in transcatheter aortic valve replacements with the Lotus Valve system.
    Catheter Cardiovasc Interv. 2017 Dec 6. doi: 10.1002/ccd.27378.
    PubMed     Text format     Abstract available


  198. SHATILA W, Krajcer Z
    A cardiologist's nightmare: Coronary obstruction during transcatheter aortic valve implantation: How to identify patients at highest risk for this complication.
    Catheter Cardiovasc Interv. 2017;90:1198-1199.
    PubMed     Text format     Abstract available


    November 2017
  199. DANIELS DV, Banerjee S, Alaswad K, Doing AH, et al
    Safety and efficacy of the hybrid approach in coronary chronic total occlusion percutaneous coronary intervention: The Hybrid Video Registry.
    Catheter Cardiovasc Interv. 2017 Nov 29. doi: 10.1002/ccd.26501.
    PubMed     Text format     Abstract available


  200. ALKHALIL A, Golbari S, Song D, Lamba H, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27433.
    PubMed     Text format     Abstract available


  201. SILASCHI M, Conradi L, Wendler O, Schlingloff F, et al
    The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27370.
    PubMed     Text format     Abstract available


  202. THEUERLE J, Yudi MB, Farouque O, Andrianopoulos N, et al
    Utility of the ACC/AHA lesion classification as a predictor of procedural, 30-day and 12-month outcomes in the contemporary percutaneous coronary intervention era.
    Catheter Cardiovasc Interv. 2017 Nov 15. doi: 10.1002/ccd.27411.
    PubMed     Text format     Abstract available


  203. MURATA N, Takayama T, Hiro T, Hirayama A, et al
    Balloon pin-hole rupture during percutaneous coronary intervention for recurrent, calcified in-stent restenosis: A case report.
    Catheter Cardiovasc Interv. 2017 Nov 13. doi: 10.1002/ccd.27405.
    PubMed     Text format     Abstract available


  204. STAHLI BE, Gebhard C, Gick M, Ferenc M, et al
    Impact of anemia on long-term outcomes after percutaneous coronary intervention for chronic total occlusion.
    Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27412.
    PubMed     Text format     Abstract available


  205. FANARI Z, Mahmaljy H, Nandish S, Goswami NJ, et al
    Simultaneous transcatheter transfemoral aortic and transeptal mitral valve replacement using Edward SAPIEN S3.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27410.
    PubMed     Text format     Abstract available


  206. SCHOECHLIN S, Brennemann T, Allali A, Ruile P, et al
    Hemodynamic classification of paravalvular leakage after transcatheter aortic valve implantation compared with angiographic or echocardiographic classification for prediction of 1-year mortality.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27384.
    PubMed     Text format     Abstract available


    October 2017
  207. BARAN DA, Visveswaran GK, Seliem A, DiVita M, et al
    Differential responses to larger volume intra-aortic balloon counterpulsation: Hemodynamic and clinical outcomes.
    Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27387.
    PubMed     Text format     Abstract available


  208. GOYAL A, Tabak SW, Henry TD, Kobashigawa JA, et al
    Omission of heart transplant recipients from the 2017 Appropriate Use Criteria for Coronary Revascularization in patients with stable ischemic heart disease.
    Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27369.
    PubMed     Text format    


  209. ARORA S, Vaidya SR, Strassle PD, Misenheimer JA, et al
    Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27357.
    PubMed     Text format     Abstract available


  210. TUMMALA R, Banerjee K, Sankaramangalam K, Mick S, et al
    Clinical and procedural outcomes with the SAPIEN 3 versus the SAPIEN XT prosthetic valves in transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27398.
    PubMed     Text format     Abstract available


  211. DE PALMA R, Ruck A, Settergren M, Saleh N, et al
    Percutaneous axillary arteriotomy closure during transcatheter aortic valve replacement using the MANTA device.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27383.
    PubMed     Text format     Abstract available


  212. SHOEIB O, Burzotta F, Aurigemma C, Paraggio L, et al
    Percutaneous transcatheter aortic valve replacement induces femoral artery shrinkage: angiographic evidence and predictors for a new side effect.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27248.
    PubMed     Text format     Abstract available


  213. STEINBERG ZL, Morray BH, Jones TK
    Bicaval Medtronic Melody valve implantation for treatment of severe mitral regurgitation following the Mustard repair: A case report.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27373.
    PubMed     Text format     Abstract available


  214. LEE MS, Gordin JS, Stone GW, Sharma SK, et al
    Orbital and rotational atherectomy during percutaneous coronary intervention for coronary artery calcification.
    Catheter Cardiovasc Interv. 2017 Oct 17. doi: 10.1002/ccd.27339.
    PubMed     Text format     Abstract available


  215. O'NEILL J, Hogarth AJ, Pearson I, Law H, et al
    Transcoronary pacing to assess myocardial viability prior to percutaneous coronary intervention: Pilot study to assess feasibility.
    Catheter Cardiovasc Interv. 2017 Oct 16. doi: 10.1002/ccd.27349.
    PubMed     Text format     Abstract available


  216. LANDES U, Bental T, Levi A, Assali A, et al
    Temporal trends in percutaneous coronary interventions thru the drug eluting stent era: Insights from 18,641 procedures performed over 12-year period.
    Catheter Cardiovasc Interv. 2017 Oct 13. doi: 10.1002/ccd.27375.
    PubMed     Text format     Abstract available


  217. DRAFTS BC, Choi CH, Sangal K, Cammarata MW, et al
    Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27377.
    PubMed     Text format     Abstract available


  218. LIANG M, Yang S, Fu N, Lu C, et al
    Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27353.
    PubMed     Text format     Abstract available


  219. RUPARELIA N, Cao J, Newton JD, Wilson N, et al
    Paravalvular leak closure under intracardiac echocardiographic guidance.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27318.
    PubMed     Text format     Abstract available


  220. ANDO T, Akintoye E, Telila T, Briasouolis A, et al
    Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States.
    Catheter Cardiovasc Interv. 2017 Oct 9. doi: 10.1002/ccd.27362.
    PubMed     Text format     Abstract available


  221. HTUN WW, Grines C, Schreiber T
    Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic self-expandable bioprosthetic valve.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27346.
    PubMed     Text format     Abstract available


  222. CARRERAS ET, Kaneko T, Ramirez-Del Val F, Pelletier MP, et al
    Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27347.
    PubMed     Text format     Abstract available


  223. EFFRON MB, Wang TY, Fonarow GC, Henry TD, et al
    The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27145.
    PubMed     Text format     Abstract available


  224. ENEZATE T, Omran J, Al-Dadah AS, Alpert M, et al
    Fractional flow reserve versus angiography guided percutaneous coronary intervention: An updated systematic review.
    Catheter Cardiovasc Interv. 2017 Oct 5. doi: 10.1002/ccd.27302.
    PubMed     Text format     Abstract available


  225. FRANKEN M, Lemos PA
    Treating of aortic valve stenosis in real-life: A multifaceted decision-making challenge.
    Catheter Cardiovasc Interv. 2017;90:671-672.
    PubMed     Text format     Abstract available


    September 2017
  226. LIANG FW, Lee JC, Lu TH, Yin WH, et al
    Trends in proportions of hospitals and operators not meeting minimum percutaneous coronary intervention volume standards in Taiwan, 2001-2013.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27343.
    PubMed     Text format     Abstract available


  227. REDDY G, Wang Z, Nishimura RA, Greason KL, et al
    Transcatheter aortic valve replacement for stenotic bicuspid aortic valves: Systematic review and meta analyses of observational studies.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27340.
    PubMed     Text format     Abstract available


  228. IQBAL MB, Smith RD, Lane R, Patel N, et al
    The prognostic significance of incomplete revascularization and untreated coronary anatomy following percutaneous coronary intervention: An analysis of 6,755 patients with multivessel disease.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27331.
    PubMed     Text format     Abstract available


  229. ANDO T, Briasoulis A, Telila T, Afonso L, et al
    Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta-analysis.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27336.
    PubMed     Text format     Abstract available


  230. AZZALINI L, Candilio L, Carlino M, Colombo A, et al
    Intracoronary snaring of the retrograde guidewire: How to overcome extreme takeoff angles in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Sep 25. doi: 10.1002/ccd.27324.
    PubMed     Text format     Abstract available


  231. ALQAHTANI F, Aljohani S, Almustafa A, Alhijji M, et al
    Comparative outcomes of transcatheter aortic valve replacement in African American and Caucasian patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Sep 23. doi: 10.1002/ccd.27257.
    PubMed     Text format     Abstract available


  232. DREXEL T, Helmer G, Garcia S, Raveendran G, et al
    Management of left main coronary artery obstruction after transcatheter aortic valve replacement utilizing a periscope approach.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27317.
    PubMed     Text format     Abstract available


  233. AIT ICHOU J, Larivee N, Eisenberg MJ, Suissa K, et al
    The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27316.
    PubMed     Text format     Abstract available


  234. LEISTNER DM, Riedel M, Steinbeck L, Stahli BE, et al
    Real-time optical coherence tomography coregistration with angiography in percutaneous coronary intervention-impact on physician decision-making: The OPTICO-integration study.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27313.
    PubMed     Text format     Abstract available


  235. GIANNINI F, Latib A, Montorfano M, Ruparelia N, et al
    A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27319.
    PubMed     Text format     Abstract available


  236. BOEHNEL C, Rickli H, Graf L, Maeder MT, et al
    Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia-Systematic review.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27255.
    PubMed     Text format     Abstract available


  237. VAN GILS L, Kroon H, Daemen J, Ren C, et al
    Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27323.
    PubMed     Text format     Abstract available


  238. SONG Y, Gao Z, Tang X, Ma Y, et al
    Usefulness of the SYNTAX score II to validate 2-year outcomes in patients with complex coronary artery disease undergoing percutaneous coronary intervention: A large single-center study.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27321.
    PubMed     Text format     Abstract available


  239. YAHAGI K, Torii S, Ladich E, Kutys R, et al
    Pathology of self-expanding transcatheter aortic valves: Findings from the CoreValve US pivotal trials.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27314.
    PubMed     Text format     Abstract available


  240. ANDO T, Takagi H, Briasoulis A, Telila T, et al
    A systematic review of reported cases of combined transcatheter aortic and mitral valve interventions.
    Catheter Cardiovasc Interv. 2017 Sep 1. doi: 10.1002/ccd.27256.
    PubMed     Text format     Abstract available


    August 2017
  241. DHOBLE A, Bhise V, Nevah MI, Balan P, et al
    Outcomes and readmissions after transcatheter and surgical aortic valve replacement in patients with cirrhosis: A propensity matched analysis.
    Catheter Cardiovasc Interv. 2017 Aug 28. doi: 10.1002/ccd.27232.
    PubMed     Text format     Abstract available


  242. HUCZEK Z, Zbronski K, Grodecki K, Scislo P, et al
    Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Catheter Cardiovasc Interv. 2017 Aug 26. doi: 10.1002/ccd.27251.
    PubMed     Text format     Abstract available


  243. ALKHALIL A, Lamba H, Deo S, Bezerra HG, et al
    Safety of shorter length of hospital stay for patients undergoing minimalist transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 24. doi: 10.1002/ccd.27230.
    PubMed     Text format     Abstract available


  244. BHARADWAJ AS, Bhatheja S, Sharma SK, Kini AS, et al
    Utility of the guideliner catheter for percutaneous coronary interventions in patients with prior transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27211.
    PubMed     Text format     Abstract available


  245. FELDMAN T, Guerrero M
    Balloon aortic valvuloplasty in the TAVR era: Not so new but definitely improved.
    Catheter Cardiovasc Interv. 2017;90:311-312.
    PubMed     Text format     Abstract available


    July 2017
  246. VILLABLANCA PA, Mohananey D, Nikolic K, Bangalore S, et al
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2017 Jul 24. doi: 10.1002/ccd.27207.
    PubMed     Text format     Abstract available


  247. CLAESSEN BE, van den Boogert TPW, Piek JJ
    Recurrent myocardial infarction in a 47-year-old woman with a mechanical mitral valve prosthesis: Atherosclerosis, embolism, or spasm?
    Catheter Cardiovasc Interv. 2017 Jul 12. doi: 10.1002/ccd.27186.
    PubMed     Text format     Abstract available


    June 2017
  248. CARR SM, Lubbe DF, Huber PR
    Percutaneous transcatheter balloon dilatation and stenting to the inflow cannula stenosis of a left ventricular assist device.
    Catheter Cardiovasc Interv. 2017;89:1219-1223.
    PubMed     Text format     Abstract available


  249. CARRERAS ET, Barghash M, Givertz MM, Bhatt DL, et al
    A heart within a heart.
    Catheter Cardiovasc Interv. 2017;89:1239-1241.
    PubMed     Text format     Abstract available


  250. LUONG C, Starovoytov A, Heydari M, Sedlak T, et al
    Clinical presentation of patients with spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2017;89:1149-1154.
    PubMed     Text format     Abstract available


  251. KUO JA, Feezel AA, Putnam TN, Schutte DA, et al
    Melody valve implantation within freestyle stentless porcine aortic heterograft.
    Catheter Cardiovasc Interv. 2017;89:1224-1230.
    PubMed     Text format     Abstract available


  252. LUNI FK, Riaz H, Khan AR, Riaz T, et al
    Clinical outcomes associated with per-operative discontinuation of aspirin in patients with coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89:1168-1175.
    PubMed     Text format     Abstract available


  253. YAHAGI K, Ladich E, Kutys R, Mori H, et al
    Pathology of balloon-expandable transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27160.
    PubMed     Text format     Abstract available


  254. EL-SAID HG, Pockett CR, Moore JW
    Percutaneous obliteration of left ventricular cavity to eliminate aortic regurgitation and presumed coronary steal in an infant with hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27138.
    PubMed     Text format     Abstract available


  255. ORVIN K, Kornowski R
    The problem of delirium following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017;89:1292-1293.
    PubMed     Text format     Abstract available


    May 2017
  256. DOERNER J, Kupczyk PA, Wilsing M, Luetkens JA, et al
    Cerebral white matter lesion burden is associated with the degree of aortic valve calcification and predicts peri-procedural cerebrovascular events in patients undergoing transcatheter aortic valve implantation (TAVI).
    Catheter Cardiovasc Interv. 2017 May 26. doi: 10.1002/ccd.27122.
    PubMed     Text format     Abstract available


  257. SARNO G, Lagerqvist B, Olivecrona G, Varenhorst C, et al
    Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27030.
    PubMed     Text format     Abstract available


  258. TARAMASSO M, Denegri A, Kuwata S, Rickli H, et al
    Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
    Catheter Cardiovasc Interv. 2017 May 13. doi: 10.1002/ccd.27100.
    PubMed     Text format     Abstract available


  259. CONDADO JF, Corrigan FE 3rd, Lerakis S, Parastatidis I, et al
    Anatomical risk models for paravalvular leak and landing zone complications for balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26987.
    PubMed     Text format     Abstract available


  260. BRUNNER NW, Yue SF, Stub D, Ye J, et al
    The prognostic importance of the diastolic pulmonary gradient, transpulmonary gradient, and pulmonary vascular resistance in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27107.
    PubMed     Text format     Abstract available


  261. SALNA M, Khalique OK, Chiuzan C, Kurlansky P, et al
    Impact of small prosthesis size on transcatheter or surgical aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27120.
    PubMed     Text format     Abstract available


  262. OKOH AK, Chauhan D, Kang N, Haik N, et al
    The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 May 2. doi: 10.1002/ccd.27083.
    PubMed     Text format     Abstract available


  263. MORIYAMA N, Tanaka Y, Saito S
    Bailout polytetrafluoroethylene-covered stent implantation for left main bifurcation perforation using the kissing stent technique.
    Catheter Cardiovasc Interv. 2017;89:1022-1027.
    PubMed     Text format     Abstract available


  264. BOURAS G, Jhamnani S, Ng VG, Haimi I, et al
    Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.
    Catheter Cardiovasc Interv. 2017;89:984-991.
    PubMed     Text format     Abstract available


    April 2017
  265. AUFFRET V, Regueiro A, Campelo-Parada F, Del Trigo M, et al
    Feasibility, safety, and efficacy of transcatheter aortic valve replacement without balloon predilation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Apr 12. doi: 10.1002/ccd.27040.
    PubMed     Text format     Abstract available


  266. SARDAR P, Kundu A, Chatterjee S, Feldman DN, et al
    Transcatheter versus surgical aortic valve replacement in intermediate-risk patients: Evidence from a meta-analysis.
    Catheter Cardiovasc Interv. 2017 Apr 11. doi: 10.1002/ccd.27041.
    PubMed     Text format     Abstract available


    March 2017
  267. YOUNG MN, Elmariah S, Kennedy KF, Inglessis I, et al
    Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval.
    Catheter Cardiovasc Interv. 2017 Mar 22. doi: 10.1002/ccd.27018.
    PubMed     Text format     Abstract available


  268. MEDURI C, Kauten J, Vannan M, Rajagopal V, et al
    First report of a simultaneous transcatheter mitral valve-in-valve and aortic valve replacement in a left ventricular assist device patient.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26983.
    PubMed     Text format     Abstract available


  269. KOIFMAN E, Patel N, Weissman G, Kiramijyan S, et al
    Outcome of implantation of a second self-expanding valve for the treatment of residual significant aortic regurgitation.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26960.
    PubMed     Text format     Abstract available


  270. MOHAMMAD NIJRES B, Kenny D, Kazmouz S, Hijazi ZM, et al
    Transcatheter closure of unroofed coronary sinus using covered stents in an adult with drainage of the coronary sinus to the right ventricle after supra-annular tricuspid valve replacement.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26996.
    PubMed     Text format     Abstract available


  271. DEUSCHL F, Schofer N, Seiffert M, Hakmi S, et al
    Direct percutaneous transaxillary implantation of a novel self-expandable transcatheter heart valve for aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26986.
    PubMed     Text format     Abstract available


  272. ARAI T, Lefevre T, Hovasse T, Garot P, et al
    Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26982.
    PubMed     Text format     Abstract available


  273. VEJPONGSA P, Bhise V, Charitakis K, Vernon Anderson H, et al
    Early readmissions after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Mar 2. doi: 10.1002/ccd.26945.
    PubMed     Text format     Abstract available


    February 2017
  274. CONDADO JF, Maini A, Leshnower B, Thourani V, et al
    End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?
    Catheter Cardiovasc Interv. 2017 Feb 17. doi: 10.1002/ccd.26875.
    PubMed     Text format     Abstract available


  275. RAKITA V, Lakhter V, Patil P, O'Neill BP, et al
    Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2017 Feb 7. doi: 10.1002/ccd.26931.
    PubMed     Text format     Abstract available


  276. CZARNECKI A, Qiu F, Koh M, Prasad TJ, et al
    Clinical outcomes after trans-catheter aortic valve replacement in men and women in Ontario, Canada.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26906.
    PubMed     Text format     Abstract available


  277. MONTONE RA, Testa L, Fraccaro C, Montorfano M, et al
    Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26914.
    PubMed     Text format     Abstract available


    January 2017
  278. HORN P, Hellhammer K, Minier M, Stenzel MA, et al
    Deep sedation Vs. general anesthesia in 232 patients undergoing percutaneous mitral valve repair using the MitraClip(R) system.
    Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26884.
    PubMed     Text format     Abstract available


  279. ABDELGHANI M, Tateishi H, Miyazaki Y, Cavalcante R, et al
    Angiographic assessment of aortic regurgitation by video-densitometry in the setting of TAVI: Echocardiographic and clinical correlates.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26926.
    PubMed     Text format     Abstract available


    December 2016
  280. JATENE T, Castro-Filho A, Meneguz-Moreno RA, Siqueira DA, et al
    Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26837.
    PubMed     Text format     Abstract available


    November 2016
  281. FETTERLY K, Greason K, Mathew V
    Balloon Valvuloplasty to Predict X-ray Projection Angles that are Perpendicular to Cardiovascular Structures: A TAVI Patient Feasibility Study.
    Catheter Cardiovasc Interv. 2016 Nov 29. doi: 10.1002/ccd.26879.
    PubMed     Text format     Abstract available


  282. ZAMAN S, McCormick L, Gooley R, Rashid H, et al
    Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus transcatheter aortic valve.
    Catheter Cardiovasc Interv. 2016 Nov 12. doi: 10.1002/ccd.26857.
    PubMed     Text format     Abstract available


  283. CONROTTO F, D'Ascenzo F, D'Amico M, Moretti C, et al
    Outcomes of patients with low-pressure aortic gradient undergoing transcatheter aortic valve implantation: A Meta-analysis.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26839.
    PubMed     Text format     Abstract available


  284. LEHNER A, Ulrich S, Happel CM, Fischer M, et al
    Closure of very large PDA with pulmonary hypertension: Initial clinical case-series with the new Occlutech(R) PDA occluder.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26856.
    PubMed     Text format     Abstract available


    October 2016
  285. KODAMA A, Yamamoto M, Shimura T, Kagase A, et al
    Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Catheter Cardiovasc Interv. 2016 Oct 27. doi: 10.1002/ccd.26686.
    PubMed     Text format     Abstract available


  286. LOYALKA P, Nascimbene A, Schechter M, Petrovic M, et al
    Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26723.
    PubMed     Text format     Abstract available


  287. LANDES U, Sagie A, Kornowski R
    Transcatheter aortic valve implantation in degenerative sutureless perceval aortic bioprosthesis.
    Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26576.
    PubMed     Text format     Abstract available


    September 2016
  288. ACHARJI S, Agnihotri A, Carrozza J
    Transcatheter aortic valve replacement in unicuspid aortic valve stenosis (CCI-16-0461).
    Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26798.
    PubMed     Text format     Abstract available


  289. HARPER AR, Dawkins S, Newton JD
    Late subannular aortic root rupture following transcatheter aortic valve implantation presenting as ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26724.
    PubMed     Text format     Abstract available


  290. OKUYAMA K, Chakravarty T, Makkar RR
    Percutaneous transapical pseudoaneurysm closure following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Sep 13. doi: 10.1002/ccd.26494.
    PubMed     Text format     Abstract available


    August 2016
  291. HUDED CP, Huded JM, Sweis RN, Ricciardi MJ, et al
    The impact of delirium on healthcare utilization and survival after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26776.
    PubMed     Text format     Abstract available


  292. PYXARAS SA, Toth GG, Di Gioia G, Ughi GJ, et al
    Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three-dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26777.
    PubMed     Text format     Abstract available


  293. ROGGEN M, Dubois C, Gewillig M
    Coronary artery stenting in a patient with progeria.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26730.
    PubMed     Text format     Abstract available


  294. AIRHART S, Medvedev I, Dean LS
    Relative prosthesis-patient mismatch after transcatheter aortic valve replacement: The impact of morbid obesity.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26721.
    PubMed     Text format     Abstract available


  295. NAKAMURA K, Passeri JJ, Inglessis-Azuaje I
    Percutaneous closure of acute aorto-right ventricular fistula following transcatheter bicuspid aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26705.
    PubMed     Text format     Abstract available


  296. DANEK BA, Karatasakis A, Alame AJ, Nguyen-Trong PJ, et al
    Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry.
    Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26696.
    PubMed     Text format     Abstract available


  297. FERRERA C, Nombela-Franco L, Garcia E, Jimenez-Quevedo P, et al
    Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis.
    Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26671.
    PubMed     Text format     Abstract available


    July 2016
  298. MANOLY I, Hasan R, Brazier A, Farooq V, et al
    Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26610.
    PubMed     Text format     Abstract available


  299. STANGER DE, Abdulla AH, Wong FT, Alipour S, et al
    Upper gastrointestinal bleeding following transcatheter aortic valve replacement: A retrospective analysis.
    Catheter Cardiovasc Interv. 2016 Jul 9. doi: 10.1002/ccd.26650.
    PubMed     Text format     Abstract available


    June 2016
  300. TRAYNOR MM, Greason KL, Nkomo VT, Pochettino A, et al
    Assisted care as a baseline patient risk characteristic affecting the outcome of transcatheter aortic valve insertion.
    Catheter Cardiovasc Interv. 2016 Jun 8. doi: 10.1002/ccd.26580.
    PubMed     Text format     Abstract available


    March 2016
  301. CHAN AW, Wong D, Charania J
    Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis Using Lotus Valve System.
    Catheter Cardiovasc Interv. 2016 Mar 31. doi: 10.1002/ccd.26506.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: